ReviewDrug design, development and therapy2025
Immunomodulatory Activities of Thai Herbs and the Druggability of Their Bioactive Constituents: A Comprehensive Review for Potential Phytopharmaceutical Product Development.
Review in Drug design, development and therapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Thai herbs have been studied and developed as alternative or complementary medicines for several diseases. Some Thai herbs show immunomodulatory activities and might be beneficial for the development of novel phytopharmaceutical products. Purpose: This study aimed to review the immunomodulatory activities of Thai herbs to determine the druggability of the major bioactive components of these herbs. Materials and Methods: A list of 129 monographs (88 herbs) in the Thai Herbal Pharmacopoeia 2021 and its supplement from 2022 was used to review the immunomodulatory activities from various records and bibliological evidence. The potential bioactive components of these herbs were analyzed, and we determined druggability in compliance with Lipinski's rule of five. Results: Among the 74/88 (84%) herbs with immunomodulatory activity, 35 were studied in vitro and ex vivo and 39 were studied in vivo. The major immunomodulatory activity was decreased tumor necrosis factor-α (20%), interleukin-6 (15%), interleukin-1β (12%), interferon-γ (8%), and interleukin-10 (7%). Only 43/74 (58%) showed an association between their immunomodulatory activity and their major bioactive compounds. We excluded 18/43 (42%) of herbs because their bioactive compound concentration exceeded the cut-off of 10 µM, and Simplified Molecular Input Line Entry System format data were lacking. The remaining 25/43 (58%) contained 32 bioactive compounds, of which 17 were potential bioactive compounds that complied with all the criteria of Lipinski's rule of five. However, most of these potential bioactive compounds showed limitations in water solubility, and some compounds were reported to be extensively biotransformed in vivo. Conclusion: Some phytoconstituents of Thai herbs showed potential druggability as immunomodulatory agents in compliance with Lipinski's rule of five, the criteria for drug discovery. However, limitations in water solubility and metabolic stability mean these potential bioactive compounds might need some modifications for drug development. Addition of solubilizers, bioenhancers, and other drug delivery systems to improve pharmacokinetic profiles might be appropriate strategies to develop these bioactive compounds for future clinical applications.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.